since when did Rc110 fail? It was a one trick pony only treating AML through a central line which is very invasive and impractical. Since the discovery of the cardio protection and FTO they change the formulation so it can go through an IV drip and not only treat AML but also solid tumors which has dramatically expanded its commercialisation through a wide range of cancers 
- Forums
- ASX - By Stock
- [INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
since when did Rc110 fail? It was a one trick pony only treating...
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.97 |
Change
0.078(4.10%) |
Mkt cap ! $334.5M |
Open | High | Low | Value | Volume |
$1.97 | $2.02 | $1.94 | $892.7K | 450.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2564 | $1.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.99 | 9229 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2564 | 1.955 |
1 | 800 | 1.945 |
1 | 1924 | 1.935 |
2 | 11000 | 1.930 |
1 | 2604 | 1.920 |
Price($) | Vol. | No. |
---|---|---|
1.985 | 9229 | 3 |
1.995 | 17350 | 1 |
2.000 | 16250 | 3 |
2.010 | 3359 | 2 |
2.020 | 10000 | 1 |
Last trade - 11.59am 13/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.95 |
  |
Change
0.078 ( 3.52 %) |
|||
Open | High | Low | Volume | ||
$1.97 | $2.04 | $1.93 | 27545 | ||
Last updated 12.20pm 13/06/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online